Title |
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
|
---|---|
Published in |
Drug Design, Development and Therapy, June 2022
|
DOI | 10.2147/dddt.s340459 |
Pubmed ID | |
Authors |
Maria Napolitano, Ferdinando D’Amico, Elisa Ragaini, Laurent Peyrin-Biroulet, Silvio Danese |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 8% |
Unspecified | 3 | 6% |
Student > Doctoral Student | 3 | 6% |
Student > Master | 2 | 4% |
Student > Bachelor | 1 | 2% |
Other | 6 | 12% |
Unknown | 33 | 63% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 23% |
Unspecified | 3 | 6% |
Nursing and Health Professions | 1 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Social Sciences | 1 | 2% |
Other | 1 | 2% |
Unknown | 33 | 63% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2022.
All research outputs
#20,972,772
of 25,759,158 outputs
Outputs from Drug Design, Development and Therapy
#1,459
of 2,281 outputs
Outputs of similar age
#335,433
of 448,524 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 42 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,281 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,524 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.